Neogen Overview

  • Founded
  • 1982

Founded
  • Status
  • Public

  • Employees
  • 2,108

Employees
  • Stock Symbol
  • NEOG

Stock Symbol
  • Investments
  • 49

  • Share Price
  • $19.96

  • (As of Monday Closing)

Neogen General Information

Description

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Contact Information

Website
www.neogen.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Commercial Products
Stock Exchange
NAS
Primary Office
  • 620 Lesher Place
  • Lansing, MI 48912
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neogen Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.96 $20.04 $10.49 - $36.90 $4.3B 216M 3.31M -$0.04

Neogen Financials Summary

In Thousands,
USD
TTM 30-Nov-2022 FY 2022 31-May-2022 FY 2021 31-May-2021 FY 2020 31-May-2020
EV 3,231,032 2,473,862 4,603,700 3,440,386
Revenue 630,719 527,159 468,459 418,170
EBITDA 42,456 82,634 94,695 84,709
Net Income (16,230) 48,307 60,882 59,475
Total Assets 4,563,242 992,929 920,192 797,182
Total Debt 923,962 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Neogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neogen‘s full profile, request access.

Request a free trial

Neogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food an
Other Commercial Products
Lansing, MI
2,108 As of 2022
0000
0000 0000

000 00

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
00000 0000000000 000
Cranberry Township, PA
0000 As of 0000
000000 - 000

0000 0

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
00000 0000000000 000
Libourne, France
0000 As of 0000
00000
00 000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neogen Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MSA Safety Corporation Cranberry Township, PA 0000 000000 - 000
0000 00000 0000000 Private Equity-Backed Libourne, France 0000 00000 00 000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Neogen Patents

Neogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220315991-A1 Detecting salmonella from an environmental sample Pending 31-Mar-2021 000000000
US-20220062563-A1 Hypodermic interface assembly Pending 01-Sep-2020 0000000000
US-20220031961-A1 Hypodermic interface assembly Pending 28-Jul-2020 0000000000 0
US-20220031962-A1 Hypodermic interface assembly Pending 28-Jul-2020 000000000
US-D839380-S1 Bait station Active 17-Aug-2017
To view Neogen’s complete patent history, request access »

Neogen Executive Team (29)

Name Title Board Seat Contact Info
John Adent President, Chief Executive Officer & Board Member
Steven Quinlan Chief Financial Officer
Douglas Jones Chief Operating Officer, Operations & Vice President
Stephen Holmes Ph.D Managing Director, Neogen Europe Ltd
Jim Houthoofd Corporate Controller & Treasurer
You’re viewing 5 of 29 executive team members. Get the full list »

Neogen Board Members (10)

Name Representing Role Since
Catherine Woteki Neogen Board Member 000 0000
Darci Vetter Neogen Board Member 000 0000
James Borel Self Chairman & Board Member 000 0000
James Tobin Neogen Board Member 000 0000
Jeffrey Capello Neogen Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Neogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neogen Investments & Acquisitions (49)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 (00'0 0000 01-Sep-2022 0000000000 00.00 Other Commercial Products 0000 0000
0000-000 0000 01-Jul-2022 0000000000 00.000 Distributors/Wholesale 00000 000
000 00000 000 09-Dec-2021 0000000000 000.00 Laboratory Services (Healthcare) 00000000
000000 000000 30-Nov-2021 0000000000 Laboratory Services (Healthcare)
Delf (UK) 30-Nov-2021 Merger/Acquisition Industrial Chemicals 00000 000
You’re viewing 5 of 49 investments and acquisitions. Get the full list »

Neogen Subsidiaries (13)

Company Name Industry Location Founded
CAPInnoVet Pharmaceuticals Atlanta, GA 2014
000 00000 00000000 Laboratory Services (Healthcare) Spokane, WA 0000
00000 000000000000 Biotechnology Aracatuba, Brazil 0000
000000 0000000000 Laboratory Services (Healthcare) London, United Kingdom 0000
0000000000 Distributors/Wholesale Milan, Italy 0000
You’re viewing 5 of 13 subsidiaries. Get the full list »

Neogen ESG

Risk Overview

Risk Rating

Updated June, 03, 2022

19.18 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,613

Rank

00.0

Percentile

Healthcare

Industry

00 of 635

Rank

00.00

Percentile

Medical Supplies

Subindustry

00 of 59

Rank

00.00

Percentile

To view Neogen’s complete esg history, request access »